Gut and Joints: Autoimmune Research
Inflammatory bowel disease and autoimmune joint disorders share an overactive immune response. This article looks at what cell therapy research is studying in each.
- Autoimmune
- 2 min
07/28/2026
Two Conditions, One Pattern
At first glance, a disease of the bowel and a disease of the joints seem far apart. Yet Crohn’s disease, ulcerative colitis and rheumatoid arthritis have something in common: the immune system keeps driving inflammation in the body’s own tissue. That shared pattern is one reason researchers study similar cell therapies for both.
In the Digestive Tract
Clinical investigations are examining how specialized cells communicate with damaged intestinal tissue and whether they help regulate immune activity there. Research is still progressing. What it has shown so far has encouraged further study and greater interest in treatment plans built around each patient.
Researchers want to know which patients are most likely to respond, and why some respond more than others.
In the Joints
For autoimmune joint disorders, studies are evaluating whether cell therapy may help reduce inflammation, support mobility and improve quality of life over the long term. Responses differ from person to person, and every new trial gives physicians more information to work with.
Studies also follow participants for longer periods to see how lasting any changes are.
What Patients Should Know
Some practical points are worth keeping in mind:
- Regenerative care is studied alongside conventional treatment, and changes to medication belong with your treating doctor.
- A medical evaluation decides whether treatment is appropriate for you.
- Results vary between patients, and no outcome can be promised.
- Follow-up matters: at Regeneration Clinic, check-ins take place at 1, 3, 6, 9 and 12 months after treatment.
Our Cells
When treatment goes ahead, Regeneration Clinic uses mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords, produced in our in-house laboratory. Careful monitoring and clear information stay at the center of every plan.
07/28/2026
Related Articles
Frequently asked questions
Read Full FAQAnswers about safety, cost and what to expect.
Our proprietary stem cell standard, refined over 10 years of research and treatment. Sourced from Wharton’s Jelly and produced entirely in-house.
The most common side effect is temporary pain at the injection site. Headache, nausea or fatigue happen rarely and usually resolve within 24 hours. No long-term side effects have been documented to date.
In the US, FDA approval follows a long, costly path for each specific product and condition, and for most conditions mesenchymal stem cell therapy hasn’t completed that path yet. Research continues worldwide, with hundreds of clinical trials underway. Patients travel to Panama for access they can’t get at home, delivered with in-house production, image-guided precision and a team that tells them honestly what to expect.
We treat neurological, autoimmune, orthopedic and sports, cardiovascular and fertility conditions, autism, and support healthy aging. Our medical team reviews every case individually before recommending a protocol.
Yes. Treatment takes place at our clinic in Panama City. Your consultation and case review happen remotely before you book any travel.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance.

Still have a question?
Ask us directly. A patient advocate will reply personally.






